Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
Clinical trial NCT04187560 · COMPLETED
Trial details
- NCT number
- NCT04187560
- Sponsor
- LB Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2020-07-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.